Blacks with rheumatoid arthritis are only half as likely to be prescribed more effective drugs that may prevent further joint damage and disability, according to a new study published in the journal Arthritis Care & Research.
Like what you’re reading? Then LIKE us on Facebook!
For the study, researchers surveyed 5,385 rheumatoid arthritis Medicaid patients between ages 50 and 70 in California who were being treated with at least one anti-rheumatic drug between 1998 and 2005. Scientists reviewed participants’ records to identify any differences in the way patients from different racial and ethnic groups were being prescribed anti-arthritis medication, despite similar income level and arthritis severity.
In addition, researchers determined if patients were prescribed the more potent, biologic disease-modifying anti-rheumatic drugs (DMARDs), or the less powerful standard DMARDs.